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Abstract
Background: Less is known about the influence of hematocrit detection methodology on transfusion triggers.
Therefore, the aim of the present study was to compare two different hematocrit-assessing methods. In a total of
50 critically ill patients hematocrit was analyzed using (1) blood gas analyzer (ABLflex 800) and (2) the central
laboratory method (ADVIA® 2120) and compared.
Findings: Bland-Altman analysis for repeated measurements showed a good correlation with a bias of +1.39% and
2 SD of ± 3.12%. The 24%-hematocrit-group showed a correlation of r
2 = 0.87. With a kappa of 0.56, 22.7% of the
cases would have been transfused differently. In the-28%-hematocrit group with a similar correlation (r
2 = 0.8) and
a kappa of 0.58, 21% of the cases would have been transfused differently.
Conclusions: Despite a good agreement between the two methods used to determine hematocrit in clinical
routine, the calculated difference of 1.4% might substantially influence transfusion triggers depending on the
employed method.
Findings
Measurement of hemoglobin or hematocrit is of major
importance in contemporary patient care. Anemia or
traumatic/surgical blood loss might require transfusion
of red blood cells (RBC) to increase oxygen delivery and
counteract tissue hypoxia. However, clear transfusion
triggers are difficult to define because there is no clear
delineation between risk and benefit. To date, at least 3
large randomized controlled trials have compared
restrictive transfusion triggers to a more liberal transfu-
sion regime in critically ill adult patients[1], pediatric
intensive care patients[2] and premature infants [3]. All
three studies showed that a restrictive transfusion
regime reduced RBC transfusion requirements without
increasing morbidity and mortality. In this context,
hemoglobin concentrations ranging from 7-9 g/dl were
compared to 10-12 g/dl.
In this context, we have observed a discrepancy
between the hematocrit values determined by routine
arterial blood gas analysis compared to routine analysis
in our central laboratory. Therefore, we analyzed 250
blood samples taken from 50 critically ill patients. The
aims were (1) to compare two different hematocrit-test-
ing methods routinely used in our intensive care unit
(ICU) and hospital (central laboratory) and (2) to deter-
mine whether these two methods might provide differ-
ent transfusion triggers.
In accordance with the principles outlined by the
World Medical Association declaration of Helsinki and
following approval by the local Ethics Committee which
waived the need for written informed consent for this
post hoc data analysis, patient data from 50 patients
treated on our intensive care unit from November 2007
to March 2008 were analyzed retrospectively. A total of
50 critically ill patients treated consecutively in our
department were included irrespective of hemodynamic
stability or diagnosis for the comparison of the two
methods.
Blood was drawn daily, usually, at 6 a.m. for routine
laboratory analysis, including 2 hematograms performed
with 2 different methods. To compare hematocrit values
determined by these two different methods of analysis,
250 paired hematocrit values (data of 50 patients over 5
consecutive days resulting in 250 paired samples) were
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groups depending on the transfusion targets set during
ICU treatment. A total of 20 patients with severe trau-
matic brain injury, severe burns, following reconstruc-
tive surgery or with cardiac ischemia had a hematocrit
target of 28%. The other 30 patients had a target hema-
tocrit of 24%.
On the ICU arterial blood samples were routinely
drawn in 4 to 6 hour intervals to control paO2,p a C O 2,
hematocrit, glucose or potassium serum levels, required
to optimize ventilatory settings, guide transfusions, and
adapt intravenous infusion of insulin or potassium.
T h e s eb l o o ds a m p l e sw e r ea n a l y s e db yt h en u r s e su s i n g
the commercially available blood gas analyzer ABLflex
800 (Radiometer Medical, Copenhagen, Denmark;
http://www.Radiometer.com) located on our ICU. Blood
was drawn daily, usually, at 6 a.m. for routine laboratory
analysis. Among others, differential blood count includ-
ing analysis of hemoglobin/hematocrit was performed.
As a standardized pre- analytic procedure[4,5], at least 2
ml of blood were discarded to prevent hemodilution by
infused fluids before withdrawing blood for the actual
analysis using specialized syringes, i.e., the syringe for
the ABLflex 800 (Arterial Blood sampler 1.7 ml, Radio-
meter Copenhagen, Denmark) and vacutainers (BD
Vacutainer® K2E 5.4 mg, BD-Plymouth, PL67BP, UK)
for the ADVIA 2120.
Method 1: ABLflex 800
The specimen is drawn from the syringe into the cuv-
ette within the gas analyzer maintained at 37°C. There-
after, one microliter of the specimen is hemolized via
ultrasound (30 kHz). Hemoglobin content is assessed
spectrophotometrically using 128 different wave lengths
(478 to 672 nm). The light is transmitted via glass-fiber
optics through a diffraction gating, which diffracts the
light into 128 single wavelengths. The detecting device
consists of 128 photo diodes. According to the equation
of Lambert-Beer hemoglobin content (ctHb) of the
blood sample is determined. Based on the ctHb the
hematocrit (hct) is calculated via an internal algorithm.
Method 2: ADVIA 2120
(Siemens Medical Solutions Diagnostics, Zurich, Swit-
zerland, http://www.diagnostics.siemens.com): This
device uses 2 sequential methods of haemoglobin mea-
surement:
(1) Flow cytometry: In a first step red blood cells are
applied to iso-volumetric sphering and partial fixa-
tion. Then a second reagent encases the sample
stream and the entire specimen passes through a
flow cell. A red laser then measured cell volume and
intracellular haemoglobin concentration. The
amount of light scattered at low angle (2-3°) is
dependent on the cell volume and the high angle (5-
15°) is related to the refractive index of the cell,
reflecting the haemoglobin concentration for red
blood cells (CHCM). The haematocrit then is
calculated.
(2) A cyanide-free reagent (borate solution) and a
surfactant (N, N,-dimethyllaurylamine N-oxide)
cause haemolysis and facilitate the oxidation of
h a e m ei r o nt oF e3
+. Because of the alkaline pH of
the reagent haemoglobin loses most of its salt
bridges. The ligated heme groups are solubilized by
surfactant micelles to generate a green end-product
which can be detected photometrically[6].
During analysis both values for haemoglobin deter-
m i n e db y1a n d2a r ec o m p a r e db ya ni n t e r n a la l g o -
rithm. In case of a predefined discrepancy the
haemoglobin value is corrected in respect to the colori-
metric method which is considered as the “gold stan-
dard” [7].
Our null hypothesis was that the two different meth-
ods (ABLflex 800 and ADVIA 2120) were equal and did
not provide different transfusion triggers. The alterna-
tive hypothesis was that the ABLflex 800 method is not
equal to the ADVIA 2120 method.
Bland-Altman analysis corrected for repeated mea-
surements [8,9] and Cohen’s kappa statistics [10] were
used to compare the two methods (Statview 4.5, abacus
concepts, Berkeley, CA, USA). Cohen’s kappa statistics
compares the observations of two different methods and
therefore results in 4 possible cases: +/+, +/-, -/+ and
-/-. There is an agreement of the methods in the cases
of +/+ and -/- (i.e. “transfused”/“transfused” and “not
transfused”/“not transfused”) and there is no agreement
in the cases +/- and -/+ (i.e.,“transfused”/“not trans-
fused” and “not transfused”/“transfused”), respectively.
With kappa ≤ 0.4 the agreement is poor, if kappa is
between 0.4 and 0.75 agreement is fair and kappa ≥ 0.75
reflects excellent agreement between these two methods.
Comparisons between groups were calculated either
with Chi-square test, with a nonparametric Mann-Whit-
ney test or ANOVA log rank test (Statview 4.5, abacus
concepts, Berkeley, CA, USA). Statistical significance
level was accepted with p < 0.05.
The investigated 50 patients were grouped according
to the pre- defined transfusion triggers (24 and 28%)
used on our intensive care unit for different illnesses,
resulting in 30 patients within the 24-%-hematocrit-
group and 20 patients in the 28-%-hematocrit-group.
As depicted in table 1 these two hematocrit target
groups consist of heterogeneous patients with different
leading diagnosis which, in turn, dictated different treat-
ment concepts and different transfusion triggers.
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Serum levels of lactate and body temperature were sig-
nificantly different in the 2 groups (p = 0.02 and 0.04,
respectively). Hospital mortality was also significantly
different (p = 0.03).
Bland-Altman analysis for repeated measurements of
all patients showed a good agreement with a bias of
+1.39% and 2 standard deviations (2 SD) of ± 3.12%
(figure 1). Thus, the ABL800 flex method showed an
approximately 1.4% higher hematocrit than the ADVIA
2120 method. Bias for each group was not statistically
different (1.11 ± 1.83% in the 24%-hematocrit-group vs.
1.70 ± 1.24% in the 28%-hematocrit-group, p = 0.26).
According to the targeted transfusion triggers of 24%
and 28% two kappa statistical analysis were performed
in 30 patients with a transfusion trigger set at hemato-
crit of 24% and 20 patients with a hematocrit transfu-
sion trigger of 28%. In those patients with a predefined
hematocrit target of 24% (n = 150 values) both methods
showed a significant correlation of r
2 = 0.87 (figure 2).
Kappa of 0.56 indicated a fairly good agreement of the
methods, i.e., values located within the lower field below
24% (square III) reflect patients who needed to be trans-
fused according to both methods of analysis and square
I depicts those patients in whom transfusions were not
required, regardless of analytical procedure. In contrast,
s q u a r eI Is h o w s3 4p a t i e n t s( 2 2 . 7 % )w h ow o u l dh a v e
been transfused according to the hematocrit values
determined by the central laboratory. According to the
blood gas analysis, however, these patients would not
have been transfused.
In patients with predefined hematocrit target of 28%
(n = 100 values) both methods also correlated well with
Table 1 Baseline and clinical characteristics
Parameter 24%-hct-group 28%-hct-group p-value
Number of patients 30 20
Men 21 (70%) 15 (75%) 0.70
Women 9 (30%) 5 (25%) 0.70
Age (yrs.) 52.5 ± 13.6 44.8 ± 28 0.17
Heart rate (bpm) 94 ± 24 83 ± 22 0.07
MAP (mmHg) 76 ± 15 83 ± 11 0.11
Weight (kg) 87.2 ± 34.7 70.8 ± 11.4 0.10
Height (cm) 172 ± 10 174 ± 10 0.70
Diagnosis
Sepsis 11 (36.7%) 0
Lung-TPL 3 (10%) 0
Liver-TPL 2 (6.7%) 0
Fascitis 1 (3.3%) 0
Mesothelioma 1 (3.3%) 0
Liver Cirrosis 1 (3.3%) 0
Colon-Carcinoma 1 (3.3%) 0
Severe Brain injury 0 9 (45%)
Polytrauma 8 (26.7%) 2 (10%)
Severe burn injury 0 8 (40%)
ARDS 1 (3.3%) 0
Gastric bypass 1 (3.3%) 0
Cardiac arrest 0 1 (5%)
Lactat (mmol/l) 1.7 ± 1.8 1.2 ± 0.7 0.02
Temp. (°C) 37.0 ± 1.5 36.7 ± 1.3 0.04
Blood glucose
(mmol/l)
6.7 ± 1.3 6.7 ± 1.9 0.15
Norepinephrine
(microg/min)
7.9 ± 11.5 8.3 ± 12.8 0.10
SAPS II 39 ± 17 31 ± 15 0.07
Hospital mortality 15 (50%) 4 (20%) 0.03
Figure 1 Bland-Altman analysis for repeated measurements of all patients showed a good agreement with a bias of +1.39% and 2
standard deviations (2 SD) of ± 3.12%. The lower and upper limits of agreement (bias ± 2 SD) are -1.73 and 4.51%, respectively. Thus, the
ABLflex 800 method showed elevated hematocrit by approximately 1.4%.
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2 = 0.8 (figure 3). Kappa of 0.58 also reflected a fairly
good agreement of these two methods, i.e., values
located within square III below 28% reflected patients
requiring RBC transfusions according to both methods
of analysis. Square II shows 21 patients (21%) in whom
hematocrit determined by the central laboratory would
have suggested RBC transfusion while blood gas analysis
would not have indicated RBC transfusion. In square I
none of the patients would be transfused, regardless of
analytical procedure.
According to the present analysis, ADVIA 2120 and
ABLflex 800 provide similar hematocrit values. Neverthe-
less, values close to the lower transfusion/hematocrit
threshold will be strongly influenced by the employed ana-
lytical method. Thus, these methodological differences
must be considered in addition to the defined transfusion
trigger to standardize transfusion practice within the indi-
vidual ICU/hospital and across different hospitals in
multi-center trials [1]
-[3]. In this context, it is of critical
importance to use the same analytical procedure.
Analytical procedures are strongly dependent on in
vivo and in vitro influences: In this context, the preana-
lytic phase is crucial for the subsequent analytic process
[11] and most importantly for the interpretation of the
obtained results. Point-of-care testing (POCT) has been
introduced in clinical routine to provide analytical
results more rapidly and to allow shorter therapeutic
response intervals. For POCT systems like the ABLflex
800, preanalytic steps are decisive which include correct
blood withdrawal with discarding of the first sample and
immediate analysis to prevent hemodilution and stability
of the specimens, respectively. Inappropriate handling
and prolonged delay will result in sedimentation of RBC
and will interfere with subsequent analysis. Details for
preanalytics in POCT are described by Hicks et al [12].
Another important factor is the time span from blood
withdrawal to their processing within the analyzer to
optimize stability of hematological analysis which is
time-dependent and hematology analyzer dependent[13].
In our ICU the nursing staff is trained in standardized
Figure 2 In 30 patients with a predefined hematocrit target of 24% (n = 150 values) both methods showed a significant correlation of
r
2 = 0.87 and kappa was 0.56, indicating a fair agreement of the methods. Values located within the lower field below 24% (square III)
reflect patients who need to be transfused according to both methods of analysis; in contrast, square II shows 34 patients (22.7%) who would
have been transfused according to the hematocrit values determined by the central laboratory.
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within minutes after blood collection.
The samples for the ADVIA 2120 are directly sent to
the hematology laboratory, marked “emergency” which
guarantees immediate processing, providing results
w i t h i no n eh o u r .T h ep r e - a n a l y t i cp r o c e s sa n dt h er e s t
of the testing in the laboratory is highly standardized.
Thus, assuming that pre-analytic errors occurred, we
would rather have to consider this a systematic error.
The ADVIA 2120 method may be influenced by
hemolytic samples or lipemia leading to falsely elevated
hematocrit levels, in contrast cold antibodies can
decrease hematocrit. In addition, polyglobulia may affect
the measurement [14]. In our population polyglobulia or
lipemia was not present; cold antibodies were not
searched for routinely.
The International Committee for Standardization in
Hematology (ICSH) recommends the cyanmethemoglo-
bin method as a reference method for hemoglobin mea-
surement[7].
Although blood gas analyzers as POCT methods are
increasingly used to provide rapid analysis of hematocrit
in ICU, emergency departments, and operating theaters,
data showing reliability between the different methods is
scarce. A Belgian multicenter study compared different
POCT methods to standard laboratory analyzer and
found differences from 0.6 to 4.1% [15] which was cor-
roborated by two other studies[16,17].
To date, we lack detailed studies addressing the
impact of different analytical methods on the transfusion
management. Although both tested methods showed a
fair to good agreement, approximately 21% of our sam-
ples might lead to a different transfusion management.
Taken together, apart from clinical parameters transfu-
sion triggers must not only be defined as simple values
but must be considered as method-dependent para-
meters. In the literature none of the landmark papers
[1-3] mentioned the hemoglobin analyzing method.
This, in turn, could in theory, lead to different results of
these studies. Most importantly, multi-center trials must
use the same method of analysis to avoid false
transfusions.
Concerning the ICSH guidelines which recommend
the cyanmethemoglobin method as a standard method,
Figure 3 In 20 patients with predefined hematocrit target of 28% (n = 100 values) both methods correlated well with r
2 =0 . 8 ,a
kappa of 0.58 reflected a fair agreement of the methods. Values located within square III below 28% reflect patients who require RBC
transfusions according to both methods of analysis, whereas square II shows 21 patients (21%) in whom hematocrit determined by the central
laboratory would have suggested RBC transfusion while blood gas analysis would not have indicated RBC transfusion.
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measure hemoglobin/hematocrit. Nevertheless, transfus-
ing according to the ADVIA 2120 method would
increase the transfusion rate in our patients with its
additional risks.
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